Company
MMJ Group Holdings Limited
Headquarters: Sydney, NSW, Australia
Market Cap
A$11.5 Million
AUD as of Jan. 1, 2024
US$7.8 Million
MMJ Group Holdings Limited Categories
Australia Healthcare Drug Manufacturers—Specialty & GenericAustralia Healthcare Australia Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Hygrovest Limited operates as a cannabis investment company worldwide. It owns a portfolio of cannabis sector investments. The company was formerly known as MMJ Group Holdings Limited and changed its name to Hygrovest Limited in December 2021. Hygrovest Limited was incorporated in 2014 and is based in Sydney, Australia.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
MMJ Group Holdings Limited has the following listings and related stock indices.
Stock: ASX: MMJ wb_incandescent